Mereo BioPharma Group plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Mereo BioPharma Group plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2024.
  • Mereo BioPharma Group plc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $909K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $909K Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $985K Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.11M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.25M -$420K -25.2% Dec 31, 2023 10-Q 2024-11-12
Q4 2022 $1.67M Dec 31, 2022 10-K 2024-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.